Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540405 · ClinicalTrials.gov registry record · NA
Effects of Bitter Melon on Cardiometabolic Health
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT05540405 is a NA study that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 75 participants.
The verdict
NCT05540405, a NA study, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The objectives of this study are to assess the effects of a bitter melon product at two doses, compared to control, on indicators of cardiometabolic health among men and women with prediabetes.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Low-dose bitter melon
- DIETARY_SUPPLEMENT High-dose bitter melon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-01-24 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540405
The ClinicalTrials.gov registry entry for NCT05540405 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05540405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05540405 about?
NCT05540405 is a clinical study titled "Effects of Bitter Melon on Cardiometabolic Health". The objectives of this study are to assess the effects of a bitter melon product at two doses, compared to control, on indicators of cardiometabolic health among men and women with prediabetes.
What is the current status of trial NCT05540405?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2023-01-24. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05540405?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Low-dose bitter melon (DIETARY_SUPPLEMENT), High-dose bitter melon (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05540405?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.